McKesson Corporation (MCK) Stock

Healthcare · Medical Distribution · Member of S&P 500

McKesson Corporation (MCK) closed at USD 976.57 on 2026-10-14, a change of +21.9 % over the past year, with a market capitalization of USD 116.43B.

McKesson Corporation recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

McKesson Corporation key figures

Previous close

USD 976.57 (2026-10-14)

1-year change

+21.9 %

Market cap

USD 116.43B

Enterprise value

USD 126B

P/E ratio (trailing)

26.77

P/E ratio (forward)

19.75

EPS (trailing)

37.31

EPS (forward)

50.58

PEG ratio

1.84

Price to book

-27.32

Revenue growth

7.7 %

Earnings growth

-17.6 %

Dividend per share (trailing)

3.28

Short ratio

2.59

Employees

41,600

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About McKesson Corporation

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, hospital reference labs, nursing homes, hospice and home health care agencies, government facilities, and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for McKesson Corporation and compare it with other stocks.